India’s Pharma Exports Face Potential Rs 5K Crore Loss Amid Ongoing West Asia Conflict

India’s pharmaceutical industry is facing significant challenges due to escalating tensions in West Asia, which could lead to potential losses ranging from Rs 2,500 to Rs 5,000 crore if exports to the Gulf Cooperation Council (GCC) and the wider West Asia and North Africa (WANA) region are disrupted. The ongoing conflict is straining freight and shipping routes, impacting delivery schedules for critical pharmaceutical products. As the situation develops, industry leaders are urging for immediate measures to mitigate the risks associated with these disruptions.

Impact on Pharmaceutical Exports

The GCC countries currently represent 5.58% of India’s total exports, with pharmaceuticals playing an increasingly vital role in this trade. Recent data indicates a rise in Indian pharmaceutical exports to the WANA region, climbing from $1,320.44 million in FY 2020-21 to $1,749.68 million in FY 2024-25. Nations such as the UAE, Saudi Arabia, Oman, Kuwait, and Yemen depend heavily on India for affordable medicines. However, this growth trajectory is now threatened by the ongoing conflict, which has created significant challenges in the global freight market.

Emerging markets like Jordan, Kuwait, and Libya have also shown increasing demand for Indian pharmaceuticals, including vaccines, surgical products, and AYUSH formulations. The potential disruption of exports to these regions could have far-reaching consequences, not only for Indian pharmaceutical companies but also for the healthcare systems in these countries that rely on timely access to essential medications.

Challenges in Shipping and Logistics

Namit Joshi, Chairman of the Pharmaceuticals Export Promotion Council of India (Pharmexcil), highlighted that the tensions in West Asia are affecting critical maritime and air cargo corridors. Key shipping routes, including the Red Sea, Strait of Hormuz, and Gulf shipping corridors, are experiencing heightened risks of rerouting and delays. This situation poses a particular threat to temperature-sensitive products, which are vulnerable to damage from prolonged transit times or disruptions in cold-chain logistics.

The ongoing conflict has already placed considerable strain on the global freight market, with reports indicating that freight charges for both imports and exports have doubled in some instances. Joshi noted that surcharges ranging from $4,000 to $8,000 per shipment are exerting substantial pressure on Indian pharmaceutical companies, complicating their ability to maintain competitive pricing and timely deliveries.

Rising Costs and Supply Chain Concerns

In addition to shipping challenges, the pharmaceutical supply chain is facing escalating costs driven by various factors. Fluctuations in crude oil prices, increasing logistics costs for active pharmaceutical ingredients (APIs) and finished formulations, and shipping delays are all contributing to a more complex operational environment. These rising costs are expected to affect inventory cycles, further complicating the ability of companies to meet market demands.

Pharmexcil is actively monitoring the situation and engaging with logistics and trade stakeholders to implement damage control measures. The organization has recommended closer coordination with government authorities to explore potential freight relief measures, as well as the diversification of shipping routes and alternative logistics options. Continued dialogue with international regulators is also essential to ensure the timely availability of medicines in key markets.

Future Strategies and Recommendations

As the pharmaceutical sector navigates these challenges, Pharmexcil emphasizes the importance of proactive strategies to mitigate risks. The organization is advocating for enhanced collaboration with government bodies to address the pressing issues arising from the conflict. By exploring alternative logistics options and diversifying shipping routes, Indian pharmaceutical companies can better position themselves to withstand the pressures of the current geopolitical climate.

Furthermore, maintaining open lines of communication with international regulators will be crucial in ensuring that essential medicines remain accessible in critical markets. As the situation evolves, the industry remains vigilant, prepared to adapt to the changing landscape while striving to uphold its commitment to providing affordable healthcare solutions both domestically and abroad.

Observer Voice is the one stop site for National, International news, Sports, Editor’s Choice, Art/culture contents, Quotes and much more. We also cover historical contents. Historical contents includes World History, Indian History, and what happened today. The website also covers Entertainment across the India and World.

Follow Us on Twitter, Instagram, Facebook, & LinkedIn